Delhi High Court quashes the ban of oxytocin drug

Delhi High Court has quashed the Health Ministry’s ban on the sale of Oxytocin by private players on the grounds that the government did not have scientific basis for banning the drug and it also did not consider the dangers to the users of the drug by this ban. The court has considered lack of evidence or scientific reasoning for the harmful effect of oxytocin. In fact, oxytocin is used to induce labour in pregnant women and stall postpartum bleeding which is a leading cause of maternal deaths.

Earlier the health ministry has banned production of oxytocin and allowed only Karnataka Antibiotics Ltd to produce the drug. Mylan, Pfizer and Indian Drug Network has moved the high court to quash the ban of the drug

Be the first to comment

Leave a Reply

Your email address will not be published.